GSK tests epilepsy med in ALS; Court denies Amgen again over Neupogen biosimilar;

@FiercePharma: GlaxoSmithKline to close Pittsburgh office, consolidate consumer ops in New Jersey. News | Follow @FiercePharma

@EricPFierce: Sanofi Pasteur is adding a fill/finish facility at US site as part of dengue vax plan. More from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: ICYMI yesterday: AbbVie moves closer to Japan's crowded hep C field with priority review nod. Article | Follow @CarlyHFierce

> GlaxoSmithKline ($GSK), the ALS Association, the Harvard Stem Cell Institute and Massachusetts General Hospital Neurological Clinical Research Institute are teaming up to investigate Glaxo's epilepsy med retigabine in ALS. More

> The U.S. District Court for the Northern District of California has denied a motion from Amgen ($AMGN) for a preliminary injunction pending appeal that would delay the launch of Novartis' ($NVS) Neupogen biosimilar, Zarxio. More

> Shanghai Fosun Pharmaceutical Group rose to a record in Hong Kong trading after saying it would raise as much as 5.8 billion yuan ($936 million) by selling shares. More

> North Carolina's Quantum Pharma has announced the acquisition of Lamda Limited, Lamda Laboratories SA and Lamda Pharmaceuticals SA for a total consideration of €9.7 million. Report

> The Florida House has OK'ed a "Right to Try" bill that would let patients near death try experimental drugs that are not yet been approved by the FDA. More

> The use of e-cigarettes is rising sharply among teenagers, according to a new report. More (sub. req.)

Medical Device News

@FierceMedDev: ICYMI: PatientsLikeMe and Biogen reveal positive data from wearable device study for MS. Report | Follow @FierceMedDev

@VarunSaxena2: Alcon intraocular lens gets FDA's stringent PMA approval. News | Follow @VarunSaxena2

@EmilyWFierce: Focus Diagnostics gets FDA nod for rapid strep test. FierceDiagnostics article | Follow @EmilyWFierce

> EndoGastric skips toward positive study review for GERD device. More

> Q1 med tech venture dips to lowest since 2013--but med tech IPOs outpace biotech. Report

Biotech News

@FierceBiotech: EuroBiotech Report: Israel awaits $250M fund, ThromboGenics spins out oncology asset, MolMed licenses CAR-T. More | Follow @FierceBiotech

@JohnCFierce: Trending: The flimsy case for a miracle ALS drug collapses under expert scrutiny. Editor's corner | Follow @JohnCFierce

> AstraZeneca's '$3B' lung cancer drug impresses in a Phase II race with Clovis. More

> The FDA calls on Genervon to release data from controversial ALS study. Story

> Atlas Venture unveils a $280M pure play biotech startup fund. Report

And Finally... Could maple syrup help to reduce antibiotic use? More